Leona Reilly

Leona Reilly shared a link
2025-07-31 08:42:03

The ImmuBridge™ platform embodies cutting-edge advancements in oncology and immunotherapy. Leveraging this platform, we can develop trispecific antibodies targeting a variety of immune and tumor cell antigens to activate diverse immune mechanisms, fostering precise and efficient cancer therapeutics. https://www.immubridge.com/trispecific-antibody-development.html

The ImmuBridge™ platform embodies cutting-edge advancements in oncology and immunotherapy. Leveraging this platform, we can develop trispecific antibodies targeting a variety of immune and tumor cell antigens to activate diverse immune mechanisms, fostering precise and efficient cancer therapeutics. https://www.immubridge.com/trispecific-antibody-development.html

Trispecific Antibody Development - Protheragen
Utilizing the ImmuBridge™️ platform, we are capable of designing and developing trispecific antibodies that specifically target a spectrum of immune and tumor cell surface antigens, catering to a wide array of requirements within the realm of cancer therapeutic applications.

0 Comments 0 Shares 925 Views 0 Reviews

Please log in to like, share and comment!
Leona Reilly shared a link
2025-07-31 08:41:41

In the cutting-edge field of biological research, the development of bispecific antibodies has emerged as a revolutionary approach to cancer therapy. This innovative technology features unique design and mechanisms of action, holding significant promise in the therapeutics of various malignancies. https://www.immubridge.com/bite-antibody-development.html

In the cutting-edge field of biological research, the development of bispecific antibodies has emerged as a revolutionary approach to cancer therapy. This innovative technology features unique design and mechanisms of action, holding significant promise in the therapeutics of various malignancies. https://www.immubridge.com/bite-antibody-development.html

BiTE Antibody Development - Protheragen
With the ImmunBridge™️ platform, we can design and develop bispecific T cell engagers (BiTEs) targeting specific tumor antigens to achieve precise targeting of cancer cells and effective therapeutics.

0 Comments 0 Shares 863 Views 0 Reviews

Please log in to like, share and comment!
Leona Reilly shared a link
2025-07-31 08:40:40

Multispecific antibodies have emerged as indispensable assets in the realms of biomedical exploration and therapy. Their extraordinary capability to engage with multiple antigens renders them invaluable across a spectrum of applications. https://www.immubridge.com/applications.html

Multispecific antibodies have emerged as indispensable assets in the realms of biomedical exploration and therapy. Their extraordinary capability to engage with multiple antigens renders them invaluable across a spectrum of applications. https://www.immubridge.com/applications.html

Applications - Protheragen
Based on the ImmuBridge™️ platform, we can design and develop multispecific antibodies targeting a range of T cell surface molecules and tumor surface antigens to meet diverse requirements in cancer therapeutic applications.

0 Comments 0 Shares 874 Views 0 Reviews

Please log in to like, share and comment!
Leona Reilly added blog Health
2025-07-30 08:36:55

Cost-effective Animal Disease Models to Power Up Life Science Research
A wide range of cost-effective animal models, from Drosophila to non-human primates, from knockout models to different disease models, are released. In a pioneering effort to revolutionize life science research, a wide range of cost-effective animal disease models, from Drosophila to non-human primates, from knockout models to different disease models, are released. These groundbreaking...

0 Comments 0 Shares 2K Views 0 Reviews

Please log in to like, share and comment!
Leona Reilly added blog Health
2025-07-30 08:36:09

Protheragen Unveils Revolutionary EndureCAR-T™ Cell Therapy Platform
Protheragen offers a variety of CAR-T cell therapy services, including personalized CAR-T cell analysis and therapy regimens based on a variety of disease models. Protheragen is an advanced CAR-T cell therapy service provider. With its extensive experience in cell therapy development and EndureCART™ technology platform, Protheragen provides investigators a wide range of disease models to...

0 Comments 0 Shares 2K Views 0 Reviews

Please log in to like, share and comment!